Shire Increases Access to Medicine through Shire Cares Initiative

Primary tabs

Shire Increases Access to Medicine through Shire Cares Initiative

Tuesday, October 18, 2016 - 4:00pm

CONTENT: Blog

We believe that the costs associated with medical treatments should not be a barrier to patient access. Today, only a few countries have a dedicated process to review and fund medicines for rare diseases. In the US we provide patient assistance programs to help those struggling to afford the treatments their physicians have prescribed. We are also working to develop a global environment in which treatments can better reach those who need them. We can only do this through partnering with the rare disease community to support and inform all those involved in making decisions about the regulation, funding, and policy for rare diseases.

We don’t want cost to stand in the way of a better life, so we’ve developed Shire Cares™— an initiative in the US dedicated to helping patients with limited financial resources and no prescription insurance. Since we created the Shire Cares Patient Assistance & Support Program, tens of thousands of patients in the US with a variety of specialty conditions have been able to access Shire medication and treatments. Currently conditions include mild to moderate ulcerative colitis, Attention Deficit/Hyperactivity Disorder (ADHD), moderate to severe Adult Binge Eating Disorder (BED), epilepsy, trigeminal neuralgia and end-stage renal disease. 

To read more, visit Shire's 2015 Annual Responsibility Report.

Keywords: Health & Healthcare | Access to Medicines | Access to care | Corporate Social Responsibility | Patient Assistance | Research, Reports & Publications | Shire Cares | Shire Pharmaceuticals | affordable care | rare diseases

CONTENT: Blog